Compare intra pritoneal Bupivacine and Petedin with intravenous analgesics to prevent post operation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016030120258N3

Enrollment

Registered

2016-03-07

Start date

2013-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cholecystectomy. Acute cholecystitis

Interventions

Intervention 1: first group intervention we injected 40 ml of 0.25 % bupivacaine intrapritoneally?. Intervention 2: Second group intervention received 25 mg of Petedin diluted in 40 ml normal saline

Treatment - Drugs

first group intervention we injected 40 ml of 0.25 % bupivacaine intrapritoneally?

Second group intervention received 25 mg of Petedin diluted in 40 ml normal saline interapretoneally?

Third group treated with interavenous analgesics.

Eligibility

Sex/Gender

All

Age

20 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:20-75 years; gall stone without symptom; no history of heart disease; lung and kidney; impassibility Bupivacine and Petedin Exclusion criteria: Gallstones complicated; allergy to bupivacine; Heart failure class 3 and 4; end stage renal disease; Open cholecystectomy ;addiction

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: after operation,6 hours after operation,12hours after operation,24 hours after operation. Method of measurement: Visual Analogue Scale.	—

Secondary

Measure	Time frame
Nausa and vomitting. Timepoint: after operation,6 and 12 and 24 hours after operation. Method of measurement: Observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Shahin fateh

Valiasr Hospital

dr.norouziAzrzkmu.ac.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026